TYPE-II DIABETES - SEARCH FOR PRIMARY DEFECTS

被引:8
作者
TURNER, R
HATTERSLEY, A
COOK, J
机构
[1] The Diabetes Research Laboratories, Radcliffe Infirmary, Oxford
关键词
TYPE-2; DIABETES; INHERITANCE; PATHOPHYSIOLOGY; GENE MUTATIONS;
D O I
10.3109/07853899209167004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 diabetes is a familial disease, but recent analysis of nuclear families indicates it is unlikely to be due to a single dominant gene with high penetrance and that it could be polygenic. Insulin resistance is a major feature, with obesity being a major determinant. Beta cell deficiency is a sine qua non of Type 2 diabetes. It is possible that obesity, insulin resistance independent from obesity and impaired beta cell function are independently inherited factors. None of these can be said to be 'primary' as diabetes usually results from the interaction of several geometric and environmental factors. This makes linkage analysis of Type 2 diabetes of uncertain benefit, since heterogeneity can occur within a pedigree. The only mutation so far discovered is of glucokinase producing maturity-onset diabetes of the young, that has a clearly defined and unusual phenotype. Identification of genes that cause classical Type 2 diabetes is likely to come from population association studies, molecular scanning techniques and direct sequencing of candidate genes rather than linkage analysis.
引用
收藏
页码:511 / 516
页数:6
相关论文
共 50 条
[41]   Pancreatic β-cell defects in women at risk of type 2 diabetes [J].
Pimenta, WP ;
Rudge, MVC ;
Aragon, FF ;
Padovani, CR .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 63 (02) :87-92
[42]   Molecular Defects in Insulin Secretion in Type-2 Diabetes [J].
Frances M. Ashcroft ;
Patrik Rorsman .
Reviews in Endocrine and Metabolic Disorders, 2004, 5 :135-142
[43]   Type 2 diabetes: simple, dual or multiple pathogenetic defects? [J].
Del Prato, S ;
Coppelli, A ;
Marchetti, P .
METABOLIC SYNDROME: DIABETES, OBESITY, HYPERLIPIDEMIA AND HYPERTENSION, 2003, 1253 :95-103
[44]   Molecular defects in insulin secretion in type-2 diabetes [J].
Ashcroft, FM ;
Rorsman, P .
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2004, 5 (02) :135-142
[45]   The Vascular Trigger of Type II Diabetes Mellitus [J].
Lammert, E. .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2008, 116 :S21-S25
[46]   Angiotensin II in Type 2 Diabetes Mellitus [J].
Chu, Kwan Yi ;
Leung, Po Sing .
CURRENT PROTEIN & PEPTIDE SCIENCE, 2009, 10 (01) :75-84
[47]   Metabolic surgery for type II diabetes: an update [J].
Gentileschi, Paolo ;
Bianciardi, Emanuela ;
Benavoli, Domenico ;
Campanelli, Michela .
ACTA DIABETOLOGICA, 2021, 58 (09) :1153-1159
[48]   Sweet taste and diet in type II diabetes [J].
Tepper, BJ ;
Hartfiel, LM ;
Schneider, SH .
PHYSIOLOGY & BEHAVIOR, 1996, 60 (01) :13-18
[49]   Costing of diabetes mellitus type II in Cambodia [J].
Flessa S. ;
Zembok A. .
Health Economics Review, 4 (1) :1-15
[50]   Metabolic surgery for type II diabetes: an update [J].
Paolo Gentileschi ;
Emanuela Bianciardi ;
Domenico Benavoli ;
Michela Campanelli .
Acta Diabetologica, 2021, 58 :1153-1159